Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase Deficiency
Trial details
- Registry ID
- NCT06422351
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Intervention/Treatment
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase DeficiencyNCT06422351 | RCKT | Phase 2 | Suspended | 2029-01Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |